Fundamental Analysis of AZITRA INC(NYSEARCA:AZTR) stock

Fundamental Rating

Overall AZTR gets a fundamental rating of 2 out of 10. We evaluated AZTR against 576 industry peers in the Biotechnology industry. AZTR may be in some trouble as it scores bad on both profitability and health. AZTR is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AZTR has reported negative net income.

AZTR had a negative operating cash flow in the past year.

1.2 Ratios

AZTR has a worse Return On Assets (-204.40%) than 90.23% of its industry peers.

AZTR has a worse Return On Equity (-286.82%) than 75.04% of its industry peers.

		Industry Rank	Sector Rank
ROA	-204.4%
ROE	-286.82%
ROIC	N/A

ROA(3y)-174.1%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AZTR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AZTR does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, AZTR has less shares outstanding

The debt/assets ratio for AZTR has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -15.34, we must say that AZTR is in the distress zone and has some risk of bankruptcy.

AZTR's Altman-Z score of -15.34 is on the low side compared to the rest of the industry. AZTR is outperformed by 84.12% of its industry peers.

A Debt/Equity ratio of 0.01 indicates that AZTR is not too dependend on debt financing.

The Debt to Equity ratio of AZTR (0.01) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Altman-Z	-15.34

ROIC/WACCN/A

WACC6.19%

2.3 Liquidity

A Current Ratio of 2.80 indicates that AZTR has no problem at all paying its short term obligations.

AZTR's Current ratio of 2.80 is on the low side compared to the rest of the industry. AZTR is outperformed by 68.94% of its industry peers.

A Quick Ratio of 2.80 indicates that AZTR has no problem at all paying its short term obligations.

AZTR's Quick ratio of 2.80 is on the low side compared to the rest of the industry. AZTR is outperformed by 67.54% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.8
Quick Ratio	2.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for AZTR have decreased strongly by -75.51% in the last year.

Looking at the last year, AZTR shows a very strong growth in Revenue. The Revenue has grown by 145.00%.

Measured over the past years, AZTR shows a quite strong growth in Revenue. The Revenue has been growing by 16.85% on average per year.

EPS 1Y (TTM)-75.51%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%39.45%

Revenue 1Y (TTM)145%

Revenue growth 3Y16.85%

Revenue growth 5YN/A

Sales Q2Q%-100%

3.2 Future

Based on estimates for the next years, AZTR will show a very strong growth in Earnings Per Share. The EPS will grow by 21.60% on average per year.

AZTR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 73.27% yearly.

EPS Next Y82.2%

EPS Next 2Y34.98%

EPS Next 3Y21.6%

EPS Next 5YN/A

Revenue Next Year-100%

Revenue Next 2Y-41.42%

Revenue Next 3Y-25.99%

Revenue Next 5Y73.27%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AZTR. In the last year negative earnings were reported.

Also next year AZTR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

AZTR's earnings are expected to grow with 21.60% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y34.98%

EPS Next 3Y21.6%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AZTR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AZITRA INC

NYSEARCA:AZTR (7/1/2024, 3:15:02 PM)

After market: 3.15 -0.25 (-7.35%)

3.4

+0.63 (+22.74%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap97.92M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-204.4%
ROE	-286.82%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.09

Health

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	2.8
Quick Ratio	2.8
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-75.51%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y82.2%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)145%

Revenue growth 3Y16.85%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

AZITRA INC (AZTR)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens